Luciferase Reporter Cell Line - C2C12

C2C12 is a mature murine myoblast cell line, originally isolated from the thigh muscles of C3H mice, and is now widely utilized as an in vitro model for skeletal muscle biology. Under growth conditions, these cells exhibit a typical myoblast morphology. In high-serum culture media, they proliferate efficiently; conversely, when cultured in low-serum differentiation media, they can be induced to differentiate into multinucleated myotubes. Owing to their robust growth capacity, reproducible differentiation potential, and sensitivity to metabolic and signaling stimuli, C2C12 cells have become one of the most widely used systems for investigating myogenesis, muscle regeneration, insulin signaling, mitochondrial function, and the regulation of muscle-associated genes. The C2C12 Luciferase Reporter Cell Line is a genetically engineered derivative of the parental C2C12 cell line, into which a luciferase reporter gene cassette has been stably introduced.

The C2C12 Luciferase Reporter Cell Line holds immense value in fields such as skeletal muscle research, drug discovery and development, functional genomics, and pathway analysis. Utilizing this cell line, researchers can evaluate various compounds to investigate their effects on myoblast proliferation, myogenic differentiation, muscle hypertrophy, muscle atrophy, inflammatory responses, oxidative stress, or metabolic regulation. Through luciferase readouts, researchers can detect the activation or inhibition status of signaling pathways with exceptional sensitivity. This makes the cell line highly suitable for high-throughput and medium-throughput screening of small-molecule drugs, biologics, natural products, genetic perturbations, or environmental stimuli. In the context of muscle differentiation studies, this reporter system facilitates the quantitative analysis of changes in promoter activity or transcriptional levels during the transition from proliferating myoblasts to differentiated myotubes, thereby providing a convenient tool for identifying regulators of myogenesis. In the realm of metabolic disease research, this cell line supports investigations spanning insulin response, glucose utilization, mitochondrial activity, and lipid metabolism, as well as the mechanisms of muscle dysfunction associated with obesity, diabetes, cachexia, or age-related sarcopenia.